StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
43
This year
1
Publishing Date
2024 - 03 - 28
1
2023 - 12 - 19
1
2023 - 12 - 01
1
2023 - 11 - 20
1
2023 - 11 - 06
1
2023 - 09 - 22
1
2023 - 08 - 25
2
2023 - 06 - 30
1
2023 - 05 - 09
1
2023 - 04 - 26
1
2023 - 04 - 19
1
2023 - 03 - 24
1
2023 - 02 - 15
1
2023 - 02 - 13
1
2023 - 01 - 24
1
2023 - 01 - 23
1
2023 - 01 - 18
2
2023 - 01 - 17
1
2022 - 12 - 06
1
2022 - 11 - 03
1
2022 - 09 - 28
2
2022 - 09 - 20
1
2022 - 09 - 16
1
2022 - 09 - 13
1
2022 - 08 - 22
1
2022 - 08 - 03
1
2022 - 07 - 13
2
2022 - 06 - 20
1
2022 - 06 - 17
1
2022 - 06 - 14
1
2022 - 04 - 06
1
2022 - 03 - 17
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 22
1
2021 - 12 - 01
1
2021 - 11 - 12
1
2021 - 11 - 10
1
2021 - 10 - 08
1
Sector
Commercial services
1
Consumer non-durables
1
Health technology
43
Manufacturing
8
N/a
1
Producer manufacturing
2
Tags
Air
1
Alzheimer's
1
America
2
Approval
1
Biocanada
1
Biosimilar
2
Breast
1
Canada
1
Cancer
4
Companies
1
Covid-19
2
Disease
3
Disorders
1
Drug
4
Expansion
1
Expected
1
Fibromyalgia
1
Fibrosis
2
Genetown
1
Glaucoma
1
Global
14
Growing
2
Growth
8
Health
2
Her2
1
Her2-
1
Hypertension
1
Immunotherapy
1
Impact
1
Influenza
1
Kisqali
1
Management
2
Market
29
Medical
1
Metastatic breast cancer
1
Muscular atrophy
1
N/a
41
Neurological
1
Novartis
3
Odt
1
Partnership
1
Pharma
1
Pharmaceuticals
2
Pipeline
1
Program
1
Reach
3
Report
9
Research
3
Respiratory
1
Sclerosis
1
Tacrolimus
1
Therapeutics
4
Travel
1
Treatment
10
Vaccine
3
Entities
3m company
2
Abbott laboratories
8
Abbvie inc.
6
Aerie pharmaceuticals, inc.
1
Altimmune, inc.
1
Amgen inc.
8
Arrival
1
Astellas pharma inc
5
Astrazeneca plc
11
Autolus therapeutics plc
1
Aveo pharmaceuticals, inc.
1
Bausch health companies inc.
1
Baxter international inc.
3
Becton, dickinson and company
1
Biogen inc.
3
Brainstorm cell therapeutics inc.
1
Bristol-myers squibb company
8
Eli lilly and company
8
Evotec se
1
Galapagos nv
2
Gilead sciences, inc.
2
Glaxosmithkline plc
13
Integra lifesciences holdings corporation
1
Intra-cellular therapies inc.
1
Johnson & johnson
15
Kimberly-clark corporation
1
Liminal biosciences inc.
2
Mallinckrodt plc
1
Mannkind corporation
1
Medtronic plc
1
Novartis ag
43
Opko health, inc.
1
Pfizer, inc.
3
Ptc therapeutics, inc.
1
Reckitt benckiser group plc
1
Regeneron pharmaceuticals, inc.
1
Sanofi
15
Seagen inc.
1
Smith & nephew plc
1
Takeda pharmaceutical company limited
3
Teva pharmaceutical industries limited
1
Teva pharmaceutical industries ltd
9
Tff pharmaceuticals, inc.
1
Thermo fisher scientific inc
1
United therapeutics corporation
1
Viatris inc.
6
Symbols
AAPL
52
ABB
57
ABBV
32
ABLZF
47
ABT
92
ACAQ
37
ACM
34
ARVL
226
AZN
33
BDX
55
BNPQF
210
BNPQY
210
CNXC
39
DHR
42
DNZOF
35
DNZOY
35
DUK
45
ERIC
61
EXPR
31
EXTR
35
FE
79
FLNT
40
FNCTF
380
FST
35
GE
45
GLAXF
33
GSK
40
HON
59
HRL
32
INTC
53
JNJ
165
LLY
53
LMNR
32
LYV
53
MDT
61
MMM
42
MS
114
MSFT
62
NBR
31
NIPNF
32
NOK
199
NOKBF
200
NVS
45
NVSEF
43
ORCL
46
PCRFF
44
PCRFY
44
PHG
42
PPRUF
38
PPRUY
38
SAP
58
SAPGF
50
SNOW
93
SNY
153
SNYNF
120
SO
35
TMO
77
TOL
63
VSAC
59
VZ
57
Exchanges
Nasdaq
43
Nyse
43
Crawled Date
2024 - 03 - 28
1
2023 - 12 - 19
1
2023 - 12 - 01
1
2023 - 11 - 20
1
2023 - 11 - 06
1
2023 - 09 - 22
1
2023 - 08 - 25
2
2023 - 06 - 30
1
2023 - 05 - 09
1
2023 - 04 - 26
1
2023 - 04 - 19
1
2023 - 03 - 24
1
2023 - 02 - 15
1
2023 - 02 - 13
1
2023 - 01 - 24
1
2023 - 01 - 23
1
2023 - 01 - 18
2
2023 - 01 - 17
1
2022 - 12 - 06
1
2022 - 11 - 03
1
2022 - 09 - 28
2
2022 - 09 - 20
1
2022 - 09 - 16
1
2022 - 09 - 13
1
2022 - 08 - 22
1
2022 - 08 - 03
1
2022 - 07 - 13
2
2022 - 06 - 20
1
2022 - 06 - 17
1
2022 - 06 - 14
1
2022 - 04 - 06
1
2022 - 03 - 17
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 22
1
2021 - 12 - 01
1
2021 - 11 - 12
1
2021 - 11 - 10
1
2021 - 10 - 08
1
Crawled Time
00:00
42
00:20
9
01:00
44
02:00
25
03:00
33
04:00
19
04:20
8
05:00
23
06:00
58
07:00
34
08:00
27
08:20
4
09:00
40
10:00
30
11:00
43
11:01
1
12:00
68
12:20
14
12:30
8
13:00
26
13:15
2
13:20
7
13:30
4
14:00
33
14:15
1
14:20
10
14:30
7
14:49
1
15:00
40
15:15
1
15:20
16
15:30
14
16:00
49
16:20
3
17:00
49
18:00
48
19:00
43
20:00
35
20:20
3
21:00
26
22:00
43
23:00
40
Source
www.biospace.com
2
www.globenewswire.com
4
www.prnewswire.com
37
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVSEF
crawled time :
19:00
save search
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-28
(Crawled : 19:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
AUTL
|
$4.8
-0.83%
-0.83%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
medical
Global Progressive Ataxia and Weakness Disorders Treatment Market Report: Focus on Key Players Novartis, Pfizer, Sanofi, GlaxoSmithKline, Roche, Merck, Takeda Pharmaceuticals and Abbott Laboratories
Published:
2023-12-19
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-3.41%
|
O:
-0.39%
H:
1.49%
C:
0.32%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.97%
|
O:
0.8%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.3%
|
O:
-0.15%
H:
0.27%
C:
-1.02%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-6.78%
|
O:
0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-0.12%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-5.26%
|
O:
0.21%
H:
0.0%
C:
0.0%
disorders
treatment
pharmaceuticals
global
market
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.6
-0.69%
0.0%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
BCLI
|
$0.503
-6.99%
-7.51%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
disease
companies
health
therapeutics
market
Ewing's Sarcoma Treatment Market to grow by USD 205.09 million from 2024-2028; North America to account for 48% of market growth - Technavio
Published:
2023-11-20
(Crawled : 19:00)
- prnewswire.com
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-2.28%
|
O:
0.91%
H:
0.6%
C:
0.27%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
12.79%
|
O:
0.51%
H:
0.77%
C:
0.26%
BAX
|
$39.65
0.33%
0.0%
2.3M
|
Health Technology
|
11.45%
|
O:
0.39%
H:
0.2%
C:
-0.17%
america
treatment
growth
market
COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published:
2023-11-06
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
17.51%
|
O:
0.41%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
20.52%
|
O:
0.11%
H:
0.33%
C:
-0.98%
TEVA
|
$12.78
-3.03%
-0.24%
9M
|
Health Technology
|
45.64%
|
O:
0.22%
H:
1.49%
C:
-0.33%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-4.08%
|
O:
0.44%
H:
0.22%
C:
0.07%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-0.4%
|
O:
0.24%
H:
0.18%
C:
0.16%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-4.55%
|
O:
0.18%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
13.83%
|
O:
0.55%
H:
0.3%
C:
0.0%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
12.92%
|
O:
-0.42%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
0.95%
|
O:
-1.32%
H:
0.0%
C:
0.0%
covid-19
Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Projected to Reach $6.17 Billion by 2030: Increasing Prevalence Drives Growth
Published:
2023-09-22
(Crawled : 19:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
GLPGF
|
$35.5157
71.75%
4.8K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
LMNL
|
$8.5
0.12%
0.12%
0
|
Health Technology
|
Email alert
Add to watchlist
GLPG
|
$28.9
-1.1%
-1.11%
140K
|
Health Technology
|
Email alert
Add to watchlist
reach
treatment
fibrosis
global
growth
market
Global Hemorrhagic Shock Treatment Market Projected to Expand at a CAGR of 4.4%, Reaching $279.5 Million by 2030
Published:
2023-08-25
(Crawled : 19:00)
- prnewswire.com
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
treatment
global
market
Global Digital Dose Inhaler Market Primed for Remarkable Growth, Forecasted to Reach $53.32 Billion by 2030
Published:
2023-08-25
(Crawled : 19:00)
- prnewswire.com
OPK
|
$1.235
-1.2%
-1.21%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
MMM
|
$91.48
0.57%
0.0%
3M
|
Producer Manufacturing
|
Email alert
Add to watchlist
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
reach
global
market
United States Biosimilar Market Report 2023: Sector is Expected to Reach $50.68 Billion in 2027 at a CAGR of 40.17%
Published:
2023-06-30
(Crawled : 19:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
biosimilar
report
expected
reach
market
Sandoz strengthens pipeline expansion through partnership to develop and manufacture multiple biosimilars
Published:
2023-05-09
(Crawled : 19:00)
- globenewswire.com
EVOTF
|
News
|
$21.68
30.35%
3.2K
|
Health Technology
|
14.53%
|
O:
9.93%
H:
0.19%
C:
0.19%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.53%
|
O:
-1.24%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-11.1%
|
O:
-1.03%
H:
0.26%
C:
0.01%
partnership
pipeline
expansion
Paracetamol IV Global Market Report 2023: Enhanced Usage of Acetaminophen to Reduce the Dependence on Opioids for Pain Management Drives Growth
Published:
2023-04-26
(Crawled : 19:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-92.84%
|
O:
-1.93%
H:
0.0%
C:
-4.84%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.63%
|
O:
-2.1%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-9.23%
|
O:
-0.39%
H:
0.58%
C:
0.5%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-10.98%
|
O:
0.17%
H:
0.31%
C:
0.06%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-20.2%
|
O:
-3.56%
H:
0.0%
C:
0.0%
management
report
global
growth
market
Idiopathic pulmonary fibrosis market size to grow by USD 1,360.99 million between 2022 and 2027; Growth driven by increasing prevalence of respiratory diseases - Technavio
Published:
2023-04-19
(Crawled : 19:00)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-8.44%
|
O:
0.42%
H:
0.0%
C:
-0.53%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.66%
|
O:
0.61%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.04%
|
O:
0.34%
H:
0.28%
C:
0.25%
LMNL
|
$8.5
0.12%
0.12%
0
|
Health Technology
|
24.63%
|
O:
0.15%
H:
0.44%
C:
-0.81%
GLPG
|
$28.9
-1.1%
-1.11%
140K
|
Health Technology
|
-22.6%
|
O:
-1.25%
H:
0.4%
C:
0.32%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-8.79%
|
O:
0.05%
H:
0.11%
C:
-0.47%
respiratory
fibrosis
growth
market
Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio
Published:
2023-03-24
(Crawled : 19:00)
- prnewswire.com
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
BAX
|
$39.65
0.33%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
Email alert
Add to watchlist
cancer
growing
therapeutics
market
Disinfectants Global Market Report 2023
Published:
2023-02-15
(Crawled : 19:00)
- prnewswire.com
RBGPF
|
$52.0
6.46%
34K
|
Consumer Non-Durables
|
-26.42%
|
O:
-1.84%
H:
0.78%
C:
0.78%
RBGLY
|
$10.29
-2.05%
1.4M
|
Manufacturing
|
-27.28%
|
O:
-1.77%
H:
1.22%
C:
0.5%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
6.77%
|
O:
-1.48%
H:
0.55%
C:
0.08%
KMB
|
$125.61
-0.28%
0.0%
2.4M
|
Consumer Non-Durables
|
-1.42%
|
O:
-1.24%
H:
0.58%
C:
0.23%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-9.16%
|
O:
-0.19%
H:
0.36%
C:
-0.52%
MMM
|
$91.48
0.57%
0.0%
3M
|
Producer Manufacturing
|
-20.76%
|
O:
-1.99%
H:
0.74%
C:
-0.44%
global
report
market
DTP Vaccines Global Market Report 2023
Published:
2023-02-13
(Crawled : 19:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
28.82%
|
O:
0.34%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
6.39%
|
O:
0.27%
H:
0.42%
C:
-0.21%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-11.05%
|
O:
-0.01%
H:
0.14%
C:
-0.43%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-1.66%
|
O:
1.28%
H:
0.0%
C:
0.0%
global
report
market
Ophthalmology therapeutics market size to increase by USD 15.72 billion: North America will account for 44% of market growth - Technavio
Published:
2023-01-24
(Crawled : 19:00)
- prnewswire.com
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
1.15%
|
O:
0.15%
H:
0.75%
C:
0.71%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
10.99%
|
O:
-0.21%
H:
0.41%
C:
0.28%
america
therapeutics
growth
market
Allergy immunotherapies market: Driving factors, industry challenges, segmentation, key vendor analysis, leading countries, and market size and forecast 2023-2027 - Technavio
Published:
2023-01-23
(Crawled : 19:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-6.09%
|
O:
-0.51%
H:
0.26%
C:
-1.36%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
0.94%
|
O:
-0.56%
H:
0.48%
C:
0.36%
market
Pharmascience Canada launched (PR)pms-DEFERASIROX (TYPE J), a generic drug indicated in the management of chronic iron
Published:
2023-01-18
(Crawled : 19:00)
- biospace.com/
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
0.76%
|
O:
0.93%
H:
0.01%
C:
-1.16%
management
drug
canada
Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research
Published:
2023-01-18
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
1.0%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-14.72%
|
O:
-0.43%
H:
1.33%
C:
0.3%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-33.1%
|
O:
0.29%
H:
2.1%
C:
1.94%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-7.34%
|
O:
-0.92%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
0.96%
|
O:
-0.9%
H:
0.58%
C:
0.01%
research
report
growth
market
Multiple Sclerosis Patients in US Left Without Essential Patient Support Program Will Now Receive Equivalent Backing From Cycle Pharmaceuticals Following FDA’s Approval of TASCENSO ODT® (fingolimod)
Published:
2023-01-17
(Crawled : 19:00)
- biospace.com/
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
2.22%
|
O:
2.34%
H:
0.04%
C:
-0.87%
odt
pharmaceuticals
program
approval
sclerosis
← Previous
1
2
3
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.